Skip to content

Serotonin: all studies

Page 337 of 400: studies 3,361 to 3,370 of 3,999, newest first. Back to the serotonin overview

Research

Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects

Neuroendocrinology 2014 Julia Seibert, Cédric M. Hysek, Carlos A. Penno et al. 52 citations

3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate are widely used psychoactive substances. MDMA primarily enhances serotonergic neurotransmission, and methylphenidate increases dopamine but has no serotonergic effects. Both drugs also increase norepinephrine, resulting in sympathomimetic properties. Here we studied the effects of MDMA and methylphenidate on 24-hour plasma...

DOI: 10.1159/000364879 (opens in new tab) Methylphenidate Steroid Endocrinology Pharmacology +1

Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

Clinical Toxicology 2014 Magdalene H Y Tang, CK Ching, M. S. H. Tsui et al. 93 citations

CONTEXT: A new group of novel psychoactive substance, the N-methoxybenzyl (NBOMe) derivatives of substituted phenethylamine, has recently emerged on the drug market, among which 25I-NBOMe and 25B-NBOMe have previously been implicated in clinical intoxications and fatalities. We report two cases of acute intoxication associated with these substances. CASE DETAILS: Two male patients (17 and 31...

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

BioMed Research International 2014 Benjamin Rolland, Renaud Jardri, Ali Amad et al. 96 citations

Hallucinations are complex misperceptions, that principally occur in schizophrenia or after intoxication induced by three main classes of drugs: psychostimulants, psychedelics, and dissociative anesthetics. There are at least three different pharmacological ways to induce hallucinations: (1) activation of dopamine D2 receptors (D2Rs) with psychostimulants, (2) activation of serotonin 5HT2A...

DOI: 10.1155/2014/307106 (opens in new tab) Full text (opens in new tab) Hallucinogen Psychosis Schizophrenia object-oriented programming Dissociative +4

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug

BioMed Research International 2014 Francesco Saverio Bersani, Ornella Corazza, Gabriella Albano et al. 98 citations

Introduction. The use of novel psychoactive substances (NPSs) has rapidly increased as well as their online availability. The aim of this paper is to provide a comprehensive review of the nature and the risks associated with 25C-NBOMe, which has recently appeared in the drug market. Methods. A systematic analysis of the scientific literature and a qualitative assessment of online and media...

DOI: 10.1155/2014/734749 (opens in new tab) Full text (opens in new tab) Synthetic drugs Emerging drugs Novel psychoactive substances Research chemicals +22

The claustrum's proposed role in consciousness is supported by the effect and target localization of Salvia divinorum.

Frontiers in Integrative Neuroscience 2014 Klaus M Stiefel, Alistair Merrifield, Alex O Holcombe 59 citations

THIS ARTICLE BRINGS TOGETHER THREE FINDINGS AND IDEAS RELEVANT FOR THE UNDERSTANDING OF HUMAN CONSCIOUSNESS: (I) Crick's and Koch's theory that the claustrum is a "conductor of consciousness" crucial for subjective conscious experience. (II) Subjective reports of the consciousness-altering effects the plant Salvia divinorum, whose primary active ingredient is salvinorin A, a κ-opioid receptor...

DOI: 10.3389/fnint.2014.00020 (opens in new tab) Full text (opens in new tab) Salvia divinorum Κ-opioid receptor Claustrum consciousness Salvinorin a mechanism +1

Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca.

Current Drug Abuse Reviews 2014 Michael Winkelman 128 citations

Substances known as psychedelics, hallucinogens and entheogens have been employed in ethnomedical traditions for thousands of years, but after promising uses in the 1950's and 1960's they were largely prohibited in medical treatment and human research starting in the 1970's as part of the fallout from the war on drugs. Nonetheless, there are a number of studies which suggest that these...

DOI: 10.2174/1874473708666150107120011 (opens in new tab) Full text (opens in new tab) Psychedelic addiction treatment Psychedelic therapeutic mechanisms Psychedelic drug safety

Is recall of dreaming during anesthesia a sign of occurrence of postoperative nausea and vomiting?

Journal of Anesthesia December 2013 Tomonori Matsuyama, Hiroshi Iranami, Keisuke Fujii et al.

We examined the relationships between recall of dreaming during anesthesia and postoperative nausea and vomiting (PONV). We found a relationship between PONV within 24 h and age <50 years, use of postoperative epidural analgesia with morphine, and female gender. We also found a relationship between PONV lasting more than 24 h and dream recall. As serotonin plays an important role for both...

1127: MULTI-ORGAN FAILURE ASSOCIATED WITH INGESTION OF SYNTHETIC STREET DRUG '25I' (25I-NBOME)

December 1, 2013 Marcelo R. Malakooti, M. Friedman, Craig M. Smith

Introduction: New synthetic recreational drugs are associated with multi-organ system failure, serotonin syndrome, and even death. "25I" (25-NBOMe), also known as "Smiles" or "Nbomb," is a synthetic full agonist of 5-HT2A receptor. It has been used for psychedelic properties similar to LSD. There are few reports of this 25I toxicity in the literature. Toxic effects include hypertension,...

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

Journal of Psychopharmacology November 27, 2013 Adam Winstock, Stephen J. Kaar, Rohan Borschmann 101 citations

This paper presents original research on prevalence, user characteristics and effect profile of N,N-dimethyltryptamine (DMT), a potent hallucinogenic which acts primarily through the serotonergic system. Data were obtained from the Global Drug Survey (an anonymous online survey of people, many of whom have used drugs) conducted between November and December 2012 with 22,289 responses. Lifetime...

Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination

The International Journal of Neuropsychopharmacology October 8, 2013 Cédric M. Hysek, Linda D. Simmler, Nathalie Schillinger et al. 125 citations

Methylphenidate and 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') are widely misused psychoactive drugs. Methylphenidate increases brain dopamine and norepinephrine levels by blocking the presynaptic reuptake transporters. MDMA releases serotonin, dopamine and norepinephrine through the same transporters. Pharmacodynamic interactions of methylphenidate and MDMA are likely. This study...